Skip to main content

toppbild-press-1551x278.jpg

Price-sensitive press releases

2021-05-18
Bulletin from Moberg Pharma’s AGM on May 18[th], 2021
STOCKHOLM, May 18[th], 2021. Moberg Pharma AB (publ)’s (“Moberg Pharma” or the “Company”) Annual General Meeting took place today. The Annual General Meeting resolved in accordance with the Nomination Committee’s and Board of Directors’ proposals as set out below.
Read more
2021-05-11
Moberg Pharma AB Interim report January - March 2021
REGISTRATION PREPARATIONS FULLY UNDERWAY 
Read more
2021-04-19
Notice of Annual General Meeting in Moberg Pharma AB (publ)
Shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Tuesday, 18 May 2021.
Read more
2021-02-09
Moberg Pharmas Year-end report 2020
Financing for both MOB-015 and BUPI
Read more
2021-02-02
Moberg Pharma’s Year-end report for the financial year 2020 to be published on February 9 - Invitation to teleconference
STOCKHOLM, February 2[nd], 2021 - On February 9[th], 2021, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Year-end report for the financial year 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date.
Read more